News

Mr Baugh was most recently president and CEO of LifeCap Resources, a consulting firm for venture capital groups and early-stage science companies. Prior to founding LifeCap in 2007,

Roche had originally intended to submit its building application for the high-rise in the second quarter of 2009. However, in the course of the development work it became

Geneart will synthesize up to 600 tailor-made genes for the Wellcome Trust Sanger Institute’s research program under this contract. The genes will be used to identify mechanisms involved

In less than one hour, the Xpert MRSA/SA skin and soft tissue (SSTI) test processes specimens from suspected skin and soft tissue infection swabs to determine if a

Final results from the study, conducted at the Brain Tumor Research Center at the University of California, San Francisco, showed that Oncophage vaccination following brain cancer surgery increased

The company will focus on maximizing the current market opportunity for the FDA cleared AlloMap product, restructure its internal development program and pursue external research collaborations in lupus,

Ms Stutts will be based at Elan’s South San Francisco campus and report to Kelly Martin, CEO of Elan. She will have direct responsibility for public policy positioning

Under the terms of the merger agreement, Roche will commence a tender offer to acquire all of the outstanding shares of Memory common stock at a price of

The patent application claims compositions and methods for treating Duchenne muscular dystrophy (DMD) in humans by skipping exons in the dystrophin gene using antisense oligomers. Among the inventors